Craif (Series C)
Funding Details
Awarder
Inbox
Date Award
April 27, 2025
Vertical
Biotech and Health
Funding URL
View Funding Page
Valuation
$100,000,000
Funding Amount
$22,000,000
Company Info
Founding Year
2018
Traction
Craif has generated $5 million in revenue in 2024 and aims to reach $15 million by the end of 2025. It has partnered with over 1,000 medical institutions and about 600 pharmacies in Japan, serving around 20,000 users.
Revenue Amount
$5,000,000
Founders
Ryuichi Onose, Takao Yasui
Market
Early cancer detection
Location
Japan
Coinvestors
X&KSK, Unreasonable Group, TAUNS Laboratories, Daiwa House Industry, Aozora Bank Group
Company Description

Craif is a startup that develops an AI-powered early cancer detection software using microRNA (miRNA) and offers a noninvasive urine-based test for early cancer detection.

Links
Website
Back to HomeBack to Biotech and Health DealsView Funding Announcement